Abstract
Cimetidine 400 mg twice daily significantly increased serum concentrations and reduced apparent oral clearance of lornoxicam 8 mg twice daily in 12 healthy volunteers. Ranitidine 150 mg twice daily produced no significant changes in lornoxicam pharmacokinetics.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ankier S. I., Brimelow A. E., Crome P., Johnston A., Warrington S. J., Turner P., Ferber H. P. Chlortenoxicam pharmacokinetics in young and elderly human volunteers. Postgrad Med J. 1988 Oct;64(756):752–754. doi: 10.1136/pgmj.64.756.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ravic M., Johnston A., Turner P. Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs. Postgrad Med J. 1990;66 (Suppl 4):S30–S34. [PubMed] [Google Scholar]
- Turner P., Johnston A. Clinical pharmacokinetic studies with lornoxicam. Postgrad Med J. 1990;66 (Suppl 4):S28–S29. [PubMed] [Google Scholar]